Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

TXGTXG
Showing 8 of 10 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in 10x Genomics Inc Class A

JACOBS LEVY EQUITY MANAGEMENT, INC holds 2M shares of TXG (10x Genomics Inc Class A), worth $77.4M as of 2026-Q2. The position was decreased (-11.5% shares). TXG represents 0.3% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$77.4M

Current Shares

2M

Total Value Change

+$77.4M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2M
-11.5%
$77.4M0.3%$38.34
0
2026-Q1
Decreased
2.3M
-13.5%
$48.5M0.2%$22.62
0
2025-Q4
Decreased
2.6M
-10.4%
$43.1M0.2%$16.29
0
2025-Q3
Increased
2.9M
+22.9%
$34.5M0.1%$11.34
42
2025-Q2
Increased
2.4M
+105.5%
$27.8M0.1%$11.73
55
2025-Q1
Increased
1.2M
+3619.6%
$10.2M0.0%$9.16
45
2024-Q4
New
31,367
-
$450,4300.0%$14.35
33
2024-Q3
Exited
0
-100.0%
$00.0%$22.67
0

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used